7Baggers
 pulmatrix reports q2 2025 results and merger plans  MSN Tue, 09 Sep 2025 18:11:29 GMT

Pulmatrix, Inc
(NASDAQ:PULM) 

PULM stock logo

Pulmatrix, Inc., a clinical stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled Small Particles Easily Respirable a...

Founded: 2003
Full Time Employees: 22
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends